CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 68 enrolled
Drug / intervention
sertraline +2 moredrug
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Age 18–65 years
  • ✓Current acute unipolar depression episode
  • ✓Capacity to understand and respond to self-applied instruments
  • ✓Depression symptoms present in the last 30 days
Key exclusion· 3
  • ✕Organic brain syndrome
  • ✕Pregnancy or lactation
  • ✕Meets criteria for psychiatric hospitalization

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02901249
NCT02901249Phase 4Completed
CompareCT.gov

Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Major Depression Through Resources Available in Brazilian Public Health

Federal University of Rio Grande do Sul·interventional·Posted Sep 15, 2016·Updated Oct 14, 2020

In Brief

A Phase 4 clinical trial evaluating sertraline, Nortriptyline, and 1 other intervention for Depression. Completed, enrolled 68 participants.

Detailed Summary

To evaluate the effectiveness of one algorithm for Major Depression Disorder (MDD) using medications available in the Brazilian Public Healthcare System (SUS), and assessment of the quality of life of these patients. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of unipolar depression episodes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 15, 2016
Enrollment StartMay 1, 2010
Primary CompletionNov 1, 2014
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.8 years ago

Interventions

sertralinedrug

Nortriptylinedrug

Lithiumdrug